光医療市場：技術別（レーザー、多色偏光、フルスペクトル光、ダイクロイックランプ、発光ダイオード、蛍光ランプ）、用途別（皮膚科、疼痛管理、腫瘍学、眼科、創傷治癒、歯科処置、審美、その他）。世界の機会分析および産業予測、2020-2030年

Photomedicine Market By Technology (Lasers, Polychromatic Polarized Light, Full Spectrum Light, Dichroic Lamps, Light Emitting Diodes, Fluorescent Lamps), By Application (Dermatology, Pain Management, Oncology, Ophthalmology, Wound Healing, Dental Procedures, Aesthetics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

世界の光医療市場は、2020年には4,048百万ドルとなり、2030年には7,510百万ドルに達すると予測され、2021年から2030年までのCAGRは6.7％で成長するとされています。光医療は、光の研究とその治療応用を様々... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,939 シングルユーザーライセンスライセンス・価格情報注文方法はこちら	151	英語

サマリー

世界の光医療市場は、2020年には4,048百万ドルとなり、2030年には7,510百万ドルに達すると予測され、2021年から2030年までのCAGRは6.7％で成長するとされています。

光医療は、光の研究とその治療応用を様々な医療分野で行う学際的な科学の一分野です。この技術では、特定の波長を持つ光を損傷部位に照射することで、病気を発見し治療することができます。青色、赤色、近赤外線などさまざまな波長の光は、体への作用が異なるため、それぞれの病気の治療に利用されています。LEDやレーザーなどの様々な光源は、効果的かつ非侵襲的に病気を治療するのに役立ちます。これらの処置は低侵襲であるため、目に見える傷跡を残さず、処置は短時間で完了します。

痛みが少なく、入院期間も短いという光医療機器の利点により、この技術に対する認知度が高まっています。光医療は、多色偏光やフルスペクトル光など、さまざまな光源を用いた治療法で、皮膚や目の病気の治療に用いられています。光医療は効果的かつ低侵襲であるため、光医療機器の普及率が高まっています。さらに、タトゥーやムダ毛処理などの美容施術に使用されるケースも増えてきています。

本市場は、主に低侵襲な施術を行う消費者の審美的向上に対する需要の増加が主な要因となっています。脱毛、タトゥー除去、スキンリサーフェシングのためのレーザーガイド施術における技術的進歩は、特に女性において、美化のために増加傾向にあります。若者と高齢者は、美と健康の重要性をより強く意識するようになっている。高齢者はより若く見えることを望み、そのために美容目的の手術が行われています。光医療製品は、より低侵襲で効果的な美容整形を可能にするため、高い需要があります。
例えば、2020年10月、光医療市場の大手企業の1つでシスラム・メディカルの子会社であるAlma Laserは、肌の若返りのためにCO2レーザー、1570nmレーザー、経表皮送達のIMPACTからなるAlma Hybridプラットフォームを発売しました。したがって、主要な市場参加者によるこのような製品の発売は、さらに市場の成長を後押しします。
市場関係者は、眼科、創傷治癒、疼痛管理、歯科治療など様々な分野の光医療製品の開発に投資している。また、携帯電話やパソコンでの過度なスクリーン使用による視力障害の増加が、レーシック手術の需要を高め、市場の成長をさらに後押ししています。
THOR Small LED Cluster、THOR Medium LED Clusterなどの光医療製品は、創傷治癒や表在性筋骨格系損傷に使用されます。同様に、THOR NIR Dental Laserは、鎮痛、深部抗炎症、深部組織修復に使用されます。Alma Laserは、トリオクラスターダイオード技術をベースにしたSoprano ICE Platinumを脱毛用に提供しています。このように、幅広い製品の入手可能性の増加は、人口のためのアクセシビリティを増加させ、大幅に市場の成長を推進しています。
しかし、代替治療法の可能性や光医療機器の製品安全性の問題が、市場の成長を抑制すると予想されます。一方、パイプラインに多数の製品が存在することや、未開拓の新興国における高い市場ポテンシャルは、予測期間中の市場成長にとって魅力的な機会として機能すると予想されます。

光医療市場は、テクノロジー、アプリケーション、地域に区分されます。技術別では、レーザー、多色偏光、フルスペクトル光、ダイクロイックランプ、発光ダイオード、蛍光ランプに分類されます。用途別では、皮膚科、疼痛管理、腫瘍、眼科、創傷治癒、歯科治療、美容、その他に分類されています。地域別では、北米、欧州、アジア太平洋、中南米、中東、アフリカ（LAMEA）にわたって分析されています。
本レポートで紹介する主なプレイヤーは、Baring Private Equity Asia Limited (Lumenis Ltd.)、Angiodynamics, Inc、Apax Partners LLP.(Syneron Medical Ltd.）、Biomedical Technology Holdings Limited（Biolitec AG）、Colorado Skin and Vein、Johnson and Johnson、Koninklijke Philips N.V., PhotoMedex, Inc、Sisram Medical Ltd.(Alma Lasers Ltd.)、Thor Photomedicine Ltd.など。

ステークホルダーにとっての主なメリット
本レポートは、世界の光医療市場における現在および新興の市場動向とダイナミクスを幅広く分析し、有力な機会を特定するものです。
世界市場の競争環境を提示し、地域ごとの競争環境を予測します。
市場の成長を促進・制限する要因の包括的な分析を行っています。
地域別・国別の分析を行い、市場動向とダイナミクスを把握します。

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: PHOTOMEDICINE MARKET, BY TECHNOLOGY
4.1 Overview
4.1.1 Market size and forecast
4.2 Lasers
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Polychromatic Polarized Light
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Full Spectrum Light
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Dichroic Lamps
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Light Emitting Diodes
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Fluorescent Lamps
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: PHOTOMEDICINE MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Dermatology
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Pain Management
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Oncology
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Ophthalmology
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Wound Healing
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
5.7 Dental Procedures
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market analysis by country
5.8 Aesthetics
5.8.1 Key market trends, growth factors and opportunities
5.8.2 Market size and forecast, by region
5.8.3 Market analysis by country
5.9 Others
5.9.1 Key market trends, growth factors and opportunities
5.9.2 Market size and forecast, by region
5.9.3 Market analysis by country
CHAPTER 6: PHOTOMEDICINE MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 Europe
6.2.1 Key trends and opportunities
6.2.2 Europe Market size and forecast, by Technology
6.2.3 Europe Market size and forecast, by Application
6.2.4 Europe Market size and forecast, by country
6.2.4.1 France
6.2.4.1.1 Market size and forecast, by Technology
6.2.4.1.2 Market size and forecast, by Application
6.2.4.2 Germany
6.2.4.2.1 Market size and forecast, by Technology
6.2.4.2.2 Market size and forecast, by Application
6.2.4.3 U.K.
6.2.4.3.1 Market size and forecast, by Technology
6.2.4.3.2 Market size and forecast, by Application
6.2.4.4 Italy
6.2.4.4.1 Market size and forecast, by Technology
6.2.4.4.2 Market size and forecast, by Application
6.2.4.5 Spain
6.2.4.5.1 Market size and forecast, by Technology
6.2.4.5.2 Market size and forecast, by Application
6.2.4.6 Rest of Europe
6.2.4.6.1 Market size and forecast, by Technology
6.2.4.6.2 Market size and forecast, by Application
6.3 Asia-Pacific
6.3.1 Key trends and opportunities
6.3.2 Asia-Pacific Market size and forecast, by Technology
6.3.3 Asia-Pacific Market size and forecast, by Application
6.3.4 Asia-Pacific Market size and forecast, by country
6.3.4.1 Japan
6.3.4.1.1 Market size and forecast, by Technology
6.3.4.1.2 Market size and forecast, by Application
6.3.4.2 China
6.3.4.2.1 Market size and forecast, by Technology
6.3.4.2.2 Market size and forecast, by Application
6.3.4.3 Australia
6.3.4.3.1 Market size and forecast, by Technology
6.3.4.3.2 Market size and forecast, by Application
6.3.4.4 India
6.3.4.4.1 Market size and forecast, by Technology
6.3.4.4.2 Market size and forecast, by Application
6.3.4.5 South Korea
6.3.4.5.1 Market size and forecast, by Technology
6.3.4.5.2 Market size and forecast, by Application
6.3.4.6 Rest of Asia-Pacific
6.3.4.6.1 Market size and forecast, by Technology
6.3.4.6.2 Market size and forecast, by Application
6.4 LAMEA
6.4.1 Key trends and opportunities
6.4.2 LAMEA Market size and forecast, by Technology
6.4.3 LAMEA Market size and forecast, by Application
6.4.4 LAMEA Market size and forecast, by country
6.4.4.1 Brazil
6.4.4.1.1 Market size and forecast, by Technology
6.4.4.1.2 Market size and forecast, by Application
6.4.4.2 Saudi Arabia
6.4.4.2.1 Market size and forecast, by Technology
6.4.4.2.2 Market size and forecast, by Application
6.4.4.3 South Africa
6.4.4.3.1 Market size and forecast, by Technology
6.4.4.3.2 Market size and forecast, by Application
6.4.4.4 Rest of LAMEA
6.4.4.4.1 Market size and forecast, by Technology
6.4.4.4.2 Market size and forecast, by Application
6.5 North America
6.5.1 Key trends and opportunities
6.5.2 North America Market size and forecast, by Technology
6.5.3 North America Market size and forecast, by Application
6.5.4 North America Market size and forecast, by country
6.5.4.1 U.S.
6.5.4.1.1 Market size and forecast, by Technology
6.5.4.1.2 Market size and forecast, by Application
6.5.4.2 Canada
6.5.4.2.1 Market size and forecast, by Technology
6.5.4.2.2 Market size and forecast, by Application
6.5.4.3 Mexico
6.5.4.3.1 Market size and forecast, by Technology
6.5.4.3.2 Market size and forecast, by Application
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Baring Private Equity Asia Limited
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 AngioDynamics, Inc.
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Apax Partners Llp
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Biomedical Technology Holdings Limited
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Colorado Skin and Vein
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 johnson and johnson md&d
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 PhotoMedex, Inc.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Koninklijke Philips N.V.
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Sisram Medical Ltd.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Thor Photomedicine Ltd.
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL PHOTOMEDICINE MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 2. PHOTOMEDICINE MARKET REVENUE, FOR LASERS, BY REGION , 2020-2030,($MILLION)
TABLE 3. PHOTOMEDICINE MARKET LASERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. PHOTOMEDICINE MARKET REVENUE, FOR POLYCHROMATIC POLARIZED LIGHT, BY REGION , 2020-2030,($MILLION)
TABLE 5. PHOTOMEDICINE MARKET POLYCHROMATIC POLARIZED LIGHT BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. PHOTOMEDICINE MARKET REVENUE, FOR FULL SPECTRUM LIGHT, BY REGION , 2020-2030,($MILLION)
TABLE 7. PHOTOMEDICINE MARKET FULL SPECTRUM LIGHT BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. PHOTOMEDICINE MARKET REVENUE, FOR DICHROIC LAMPS, BY REGION , 2020-2030,($MILLION)
TABLE 9. PHOTOMEDICINE MARKET DICHROIC LAMPS BY COUNTRY, 2020-2030,($MILLION)
TABLE 10. PHOTOMEDICINE MARKET REVENUE, FOR LIGHT EMITTING DIODES, BY REGION , 2020-2030,($MILLION)
TABLE 11. PHOTOMEDICINE MARKET LIGHT EMITTING DIODES BY COUNTRY, 2020-2030,($MILLION)
TABLE 12. PHOTOMEDICINE MARKET REVENUE, FOR FLUORESCENT LAMPS, BY REGION , 2020-2030,($MILLION)
TABLE 13. PHOTOMEDICINE MARKET FLUORESCENT LAMPS BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. GLOBAL PHOTOMEDICINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 15. PHOTOMEDICINE MARKET REVENUE, FOR DERMATOLOGY, BY REGION , 2020-2030,($MILLION)
TABLE 16. PHOTOMEDICINE MARKET DERMATOLOGY BY COUNTRY, 2020-2030,($MILLION)
TABLE 17. PHOTOMEDICINE MARKET REVENUE, FOR PAIN MANAGEMENT, BY REGION , 2020-2030,($MILLION)
TABLE 18. PHOTOMEDICINE MARKET PAIN MANAGEMENT BY COUNTRY, 2020-2030,($MILLION)
TABLE 19. PHOTOMEDICINE MARKET REVENUE, FOR ONCOLOGY, BY REGION , 2020-2030,($MILLION)
TABLE 20. PHOTOMEDICINE MARKET ONCOLOGY BY COUNTRY, 2020-2030,($MILLION)
TABLE 21. PHOTOMEDICINE MARKET REVENUE, FOR OPHTHALMOLOGY, BY REGION , 2020-2030,($MILLION)
TABLE 22. PHOTOMEDICINE MARKET OPHTHALMOLOGY BY COUNTRY, 2020-2030,($MILLION)
TABLE 23. PHOTOMEDICINE MARKET REVENUE, FOR WOUND HEALING, BY REGION , 2020-2030,($MILLION)
TABLE 24. PHOTOMEDICINE MARKET WOUND HEALING BY COUNTRY, 2020-2030,($MILLION)
TABLE 25. PHOTOMEDICINE MARKET REVENUE, FOR DENTAL PROCEDURES, BY REGION , 2020-2030,($MILLION)
TABLE 26. PHOTOMEDICINE MARKET DENTAL PROCEDURES BY COUNTRY, 2020-2030,($MILLION)
TABLE 27. PHOTOMEDICINE MARKET REVENUE, FOR AESTHETICS, BY REGION , 2020-2030,($MILLION)
TABLE 28. PHOTOMEDICINE MARKET AESTHETICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. PHOTOMEDICINE MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 30. PHOTOMEDICINE MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 31. PHOTOMEDICINE MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 32. EUROPE PHOTOMEDICINE MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 33. EUROPE PHOTOMEDICINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 34. EUROPE PHOTOMEDICINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 35. FRANCE PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 36. FRANCE PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 37. GERMANY PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 38. GERMANY PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 39. U.K. PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 40. U.K. PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 41. ITALY PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 42. ITALY PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 43. SPAIN PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 44. SPAIN PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 45. REST OF EUROPE PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 46. REST OF EUROPE PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 47. ASIA-PACIFIC PHOTOMEDICINE MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 48. ASIA-PACIFIC PHOTOMEDICINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 49. ASIA-PACIFIC PHOTOMEDICINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 50. JAPAN PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 51. JAPAN PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 52. CHINA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 53. CHINA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 54. AUSTRALIA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 55. AUSTRALIA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 56. INDIA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 57. INDIA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 58. SOUTH KOREA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 59. SOUTH KOREA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 60. REST OF ASIA-PACIFIC PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 61. REST OF ASIA-PACIFIC PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 62. LAMEA PHOTOMEDICINE MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 63. LAMEA PHOTOMEDICINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 64. LAMEA PHOTOMEDICINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 65. BRAZIL PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 66. BRAZIL PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 67. SAUDI ARABIA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 68. SAUDI ARABIA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 69. SOUTH AFRICA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 70. SOUTH AFRICA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 71. REST OF LAMEA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 72. REST OF LAMEA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 73. NORTH AMERICA PHOTOMEDICINE MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
TABLE 74. NORTH AMERICA PHOTOMEDICINE MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 75. NORTH AMERICA PHOTOMEDICINE MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 76. U.S. PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 77. U.S. PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 78. CANADA PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 79. CANADA PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 80. MEXICO PHOTOMEDICINE MARKET BY TECHNOLOGY 2020-2030,($MILLION)
TABLE 81. MEXICO PHOTOMEDICINE MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 82.BARING PRIVATE EQUITY ASIA LIMITED: COMPANY SNAPSHOT
TABLE 83.BARING PRIVATE EQUITY ASIA LIMITED: OPERATING SEGMENTS
TABLE 84.BARING PRIVATE EQUITY ASIA LIMITED: PRODUCT PORTFOLIO
TABLE 85.BARING PRIVATE EQUITY ASIA LIMITED: NET SALES,
TABLE 86.BARING PRIVATE EQUITY ASIA LIMITED: KEY STRATERGIES
TABLE 87.ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
TABLE 88.ANGIODYNAMICS, INC.: OPERATING SEGMENTS
TABLE 89.ANGIODYNAMICS, INC.: PRODUCT PORTFOLIO
TABLE 90.ANGIODYNAMICS, INC.: NET SALES,
TABLE 91.ANGIODYNAMICS, INC.: KEY STRATERGIES
TABLE 92.APAX PARTNERS LLP: COMPANY SNAPSHOT
TABLE 93.APAX PARTNERS LLP: OPERATING SEGMENTS
TABLE 94.APAX PARTNERS LLP: PRODUCT PORTFOLIO
TABLE 95.APAX PARTNERS LLP: NET SALES,
TABLE 96.APAX PARTNERS LLP: KEY STRATERGIES
TABLE 97.BIOMEDICAL TECHNOLOGY HOLDINGS LIMITED: COMPANY SNAPSHOT
TABLE 98.BIOMEDICAL TECHNOLOGY HOLDINGS LIMITED: OPERATING SEGMENTS
TABLE 99.BIOMEDICAL TECHNOLOGY HOLDINGS LIMITED: PRODUCT PORTFOLIO
TABLE 100.BIOMEDICAL TECHNOLOGY HOLDINGS LIMITED: NET SALES,
TABLE 101.BIOMEDICAL TECHNOLOGY HOLDINGS LIMITED: KEY STRATERGIES
TABLE 102.COLORADO SKIN AND VEIN: COMPANY SNAPSHOT
TABLE 103.COLORADO SKIN AND VEIN: OPERATING SEGMENTS
TABLE 104.COLORADO SKIN AND VEIN: PRODUCT PORTFOLIO
TABLE 105.COLORADO SKIN AND VEIN: NET SALES,
TABLE 106.COLORADO SKIN AND VEIN: KEY STRATERGIES
TABLE 107.JOHNSON AND JOHNSON MD&D: COMPANY SNAPSHOT
TABLE 108.JOHNSON AND JOHNSON MD&D: OPERATING SEGMENTS
TABLE 109.JOHNSON AND JOHNSON MD&D: PRODUCT PORTFOLIO
TABLE 110.JOHNSON AND JOHNSON MD&D: NET SALES,
TABLE 111.JOHNSON AND JOHNSON MD&D: KEY STRATERGIES
TABLE 112.PHOTOMEDEX, INC.: COMPANY SNAPSHOT
TABLE 113.PHOTOMEDEX, INC.: OPERATING SEGMENTS
TABLE 114.PHOTOMEDEX, INC.: PRODUCT PORTFOLIO
TABLE 115.PHOTOMEDEX, INC.: NET SALES,
TABLE 116.PHOTOMEDEX, INC.: KEY STRATERGIES
TABLE 117.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 118.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 119.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 120.KONINKLIJKE PHILIPS N.V.: NET SALES,
TABLE 121.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
TABLE 122.SISRAM MEDICAL LTD.: COMPANY SNAPSHOT
TABLE 123.SISRAM MEDICAL LTD.: OPERATING SEGMENTS
TABLE 124.SISRAM MEDICAL LTD.: PRODUCT PORTFOLIO
TABLE 125.SISRAM MEDICAL LTD.: NET SALES,
TABLE 126.SISRAM MEDICAL LTD.: KEY STRATERGIES
TABLE 127.THOR PHOTOMEDICINE LTD.: COMPANY SNAPSHOT
TABLE 128.THOR PHOTOMEDICINE LTD.: OPERATING SEGMENTS
TABLE 129.THOR PHOTOMEDICINE LTD.: PRODUCT PORTFOLIO
TABLE 130.THOR PHOTOMEDICINE LTD.: NET SALES,
TABLE 131.THOR PHOTOMEDICINE LTD.: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.PHOTOMEDICINE MARKET SEGMENTATION
FIGURE 2.PHOTOMEDICINE MARKET,2020-2030
FIGURE 3.PHOTOMEDICINE MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.PHOTOMEDICINE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.PHOTOMEDICINE MARKET,BY TECHNOLOGY,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF LASERS PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF POLYCHROMATIC POLARIZED LIGHT PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF FULL SPECTRUM LIGHT PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DICHROIC LAMPS PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF LIGHT EMITTING DIODES PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF FLUORESCENT LAMPS PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 18.PHOTOMEDICINE MARKET,BY APPLICATION,2020(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF DERMATOLOGY PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF PAIN MANAGEMENT PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF ONCOLOGY PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF OPHTHALMOLOGY PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF WOUND HEALING PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF DENTAL PROCEDURES PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF AESTHETICS PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF OTHERS PHOTOMEDICINE MARKET,2020-2030(%)
FIGURE 27.PHOTOMEDICINE MARKET BY REGION,2020
FIGURE 28.FRANCE PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 29.GERMANY PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 30.U.K. PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 31.ITALY PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 32.SPAIN PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 33.REST OF EUROPE PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 34.JAPAN PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 35.CHINA PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 36.AUSTRALIA PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 37.INDIA PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 38.SOUTH KOREA PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 39.REST OF ASIA-PACIFIC PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 40.BRAZIL PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 41.SAUDI ARABIA PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 42.SOUTH AFRICA PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 43.REST OF LAMEA PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 44.U.S. PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 45.CANADA PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 46.MEXICO PHOTOMEDICINE MARKET,2020-2030($MILLION)
FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 50.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 51.COMPETITIVE DASHBOARD
FIGURE 52.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 53.BARING PRIVATE EQUITY ASIA LIMITED.: NET SALES ,($MILLION)
FIGURE 54.ANGIODYNAMICS, INC..: NET SALES ,($MILLION)
FIGURE 55.APAX PARTNERS LLP.: NET SALES ,($MILLION)
FIGURE 56.BIOMEDICAL TECHNOLOGY HOLDINGS LIMITED.: NET SALES ,($MILLION)
FIGURE 57.COLORADO SKIN AND VEIN.: NET SALES ,($MILLION)
FIGURE 58.JOHNSON AND JOHNSON MD&D.: NET SALES ,($MILLION)
FIGURE 59.PHOTOMEDEX, INC..: NET SALES ,($MILLION)
FIGURE 60.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)
FIGURE 61.SISRAM MEDICAL LTD..: NET SALES ,($MILLION)
FIGURE 62.THOR PHOTOMEDICINE LTD..: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

The global photomedicine market was valued at $4,048 million in 2020, and is estimated to reach $7,510 million by 2030, growing at a CAGR of 6.7% from 2021 to 2030.

Photomedicine is an interdisciplinary branch of science that involves the study of light and its therapeutic application in various healthcare fields. In this technology, the disease can be detected and treated by exposing the damaged area to light with specific wavelengths. Various wavelengths of light, such as blue, red, and near-infrared have a different effect on the body and are used to treat different diseases. Various light sources, such as LED and laser help to effectively and non-invasively treat the disease. As these procedures are minimally invasive, they do not leave a visible scar and the procedure is completed in a short time.

Advantages of using photomedicine devices, such as painless procedure and shorter length of hospital stay, have increased awareness about this technology. Phototherapy using different light sources, such as polychromatic polarized light and full spectrum light is used in the treatment of various skin and eye diseases. As photomedicine procedures are effective and minimally invasive, there is a rise in the adoption rate of photomedicine devices. Moreover, they are increasingly being used for aesthetic procedures, such as tattoo and unwanted hair removal.

This market is majorly driven by increase in demand by the consumer of aesthetic enhancement, which mainly comprise of minimally invasive procedures. Technological advancement in laser guided procedures for hair removal, tattoo removal, and skin resurfacing, especially in women, for beautification is on the rise. The youth and elderly are becoming more conscious of the importance of beauty and well-being. The elderly wish to look younger, which is accomplished by the use of aesthetic-enhancing operations. Photomedicine products are in high demand because they provide less invasive and effective cosmetic operations.
For instance, in October 2020, Alma Laser, one of the leading companies in the photomedicine market and a subsidiary of Sisram Medical, launched the Alma Hybrid platform, which comprises of CO2 laser, 1570nm laser, and IMPACT for trans-epidermal delivery for skin rejuvenation. Thus, launch of such products by key market players further boosts the market growth.
Market players have invested in various developing photomedicine products that aid in ophthalmological, wound healing, pain management, and wide range of dental procedures treatments. Moreover, rise in vision problems due excessive screen time on mobile and computer demand for lasik surgeries, which further drives the market growth.
Photomedicine products, such as the THOR Small LED Cluster, THOR Medium LED Cluster is used for wound healing and superficial musculoskeletal injuries. Similarly, THOR NIR Dental Laser is used for analgesia, deep anti-inflammatory & deep tissue repair. Alma Laser offers Soprano ICE Platinum based on trio clustered diode technology for hair removal. Thus, increase in availability of wide range of products increases the accessibility for the population and significantly drives the market growth.
However, availability of alternative treatment methods and product safety issues of photomedicine devices are expected to restrain the growth of the market. Conversely, presence of a plethora of products in the pipeline and high market potential in untapped emerging economies are anticipated to serve as attractive opportunities for the market growth during the forecast period.

The photomedicine market is segmented into technology, application, and region. On the basis of technology, it is classified into lasers, polychromatic polarized light, full spectrum light, dichroic lamps, light emitting diodes, and fluorescent lamps. On the basis of applications, it is segmented into dermatology, pain management, oncology, ophthalmology, wound healing, dental procedures, aesthetics, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, Middle East, and Africa (LAMEA).
The major players profiled in the report are Baring Private Equity Asia Limited (Lumenis Ltd.), Angiodynamics, Inc., Apax Partners LLP. (Syneron Medical Ltd.), Biomedical Technology Holdings Limited (Biolitec AG), Colorado Skin and Vein, Johnson and Johnson, Koninklijke Philips N.V., PhotoMedex, Inc., Sisram Medical Ltd. (Alma Lasers Ltd.), and Thor Photomedicine Ltd.

KEY BENEFITS FOR STAKEHOLDERS
This report provides an extensive analysis of the current and emerging market trends and dynamics in the global photomedicine market to identify the prevailing opportunities.
This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Region- & country-wise analysis is provided to understand the market trends and dynamics.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（薬学的薬物）の最新刊レポート

皮膚科治療薬市場レポート：2024-2034

Allied Market Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（diodes）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（薬学的薬物）の最新刊レポート

Allied Market Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（diodes）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?